MoBiTec

MoBiTec

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

MoBiTec is a long-established supplier of essential research tools, now operating as a fully integrated brand of BIOZOL GmbH. The company's core strengths lie in its niche protein expression systems, widely adopted purification consumables, and a curated portfolio of fluorescence reagents and antibodies. Its acquisition by BIOZOL in 2024 provides a robust distribution network and operational stability, positioning it as a specialized B2B provider within the broader life sciences research supply market.

Genetics & GenomicsProteomicsAntibodies

Technology Platform

Portfolio of specialized life science research tools, including non-E. coli protein expression systems, purification columns, fluorescence reagents, and niche antibodies.

Opportunities

Leveraging BIOZOL's global distribution network to significantly expand market reach for its existing product portfolio.
Growing demand in microbiome research and live biotherapeutic production presents a direct opportunity for its specialized non-E.
coli expression systems.

Risk Factors

Strategic dependency on parent company BIOZOL's priorities and resource allocation.
Intense competition from large, integrated life science suppliers in the consumables and reagents market.

Competitive Landscape

MoBiTec competes in the broad life science research tools market against giants like Thermo Fisher Scientific, Merck KGaA, and Danaher (Cytiva). Its differentiation lies in niche, specialized products like non-E. coli expression systems and specific antibodies, where it competes with smaller specialty vendors and academic spin-outs.